Veterans Administration Medical Center - Birmingham

Birmingham, Alabama 35233

1 studies enrolling now · 7 studies all time

What they study most

Advanced Lung Non-Small Cell Carcinoma, COVID-19 Infection, Hematopoietic and Lymphatic System Neoplasm, Lung Adenocarcinoma, Lung Non-Small Cell Carcinoma, Malignant Solid Neoplasm, Metastatic Lung Non-Squamous Non-Small Cell Carcinoma, Metastatic Malignant Solid Neoplasm, Metastatic Renal Cell Carcinoma, Previously Treated Non-Small Cell Lung Cancer, Prostate Cancer, Recurrent Lung Non-Small Cell Carcinoma

Studies at this site

• Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer — Recruiting now
• Testing the Addition of the Pill Chemotherapy, Cabozantinib, to the Standard Immune Therapy Nivolumab Compared to Standard Chemotherapy for Non-small Cell Lung Cancer — Running, not enrolling
• NCI COVID-19 in Cancer Patients, NCCAPS Study — Running, not enrolling
• Nivolumab in Treating Patients With Localized Kidney Cancer Undergoing Nephrectomy — Running, not enrolling
• Testing the Use of Combination Immunotherapy Treatment (N-803 [ALT-803] Plus Pembrolizumab) Against the Usual Treatment for Advanced Non-small Cell Lung Cancer (A Lung-MAP Treatment Trial) — Running, not enrolling
• S1216, Phase III ADT+TAK-700 vs. ADT+Bicalutamide for Metastatic Prostate Cancer — Completed
• Testing the Use of Targeted Treatment (AMG 510) for KRAS G12C Mutated Advanced Non-squamous Non-small Cell Lung Cancer (A Lung-MAP Treatment Trial) — Running, not enrolling